POET TECHNOLOGIES INC.
No SEC Form 4 filings for $POET in the last 30 days.
See all $POET insider activity →POET Technologies said it raised $830 million in equity this year and has $661 million in potential warrant exercises pending. The company faces overhangs including PFIC-status litigation, Celestial AI cancellation, and a 2024 audit material weakness in internal controls. A $21.14 target is tied to a 2027 revenue ramp and Lumilens/800G volume execution versus peers Lumentum and Coherent.
POET Technologies (NASDAQ:POET) rose as it reported a Q2 loss of 7 cents per share, narrower than the 8-cent estimate, and revenue of about $0.57M versus a $0.50M estimate. Revenue grew for a sixth straight quarter. POET ended with $796.3M cash after a $400M financing and a registered direct offering at $21 per unit.
POET Technologies appointed Bardia Pezeshki and Jean F. Rankin to its board of directors and accepted Jean-Louis Malinge’s resignation for personal reasons. Pezeshki has optical communications and micro-LED interconnect experience. Rankin brings public-company governance and IP expertise. CEO Suresh Venkatesan said the changes support POET’s technology commercialization and AI/data center expansion.
Over the past 7 days, alphai's AI scored 3 news stories mentioning POET (POET TECHNOLOGIES INC.). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.
Recent POET coverage spans financial news, market movers and regulation.
The article frames POET’s valuation upside as dependent on Malaysia ramp execution, while highlighting dilution and litigation overhangs.
The combination of an earnings beat, improving losses, and a large $400M registered direct offering supports near-term liquidity and sentiment, but adds dilution risk.
Board changes add governance and technical depth, but the article provides no financial targets or operational milestones.
Board refresh plus AI-infrastructure read-through may support near-term sentiment, but the article provides no new commercial contract or financial guidance.
Earnings date is the catalyst, with options-implied volatility suggesting a large post-print move risk.
alphai scores every news story that mentions POET with an AI model for sentiment and relevance, and aggregates insider trades from POET TECHNOLOGIES INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
POET Technologies said it raised $830 million in equity this year and has $661 million in potential warrant exercises pending. The company faces overhangs including PFIC-status litigation, Celestial AI cancellation, and a 2024 audit material weakness in internal controls. A $21.14 target is tied to a 2027 revenue ramp and Lumilens/800G volume execution versus peers Lumentum and Coherent.
6 min readPOET Technologies (NASDAQ:POET) rose as it reported a Q2 loss of 7 cents per share, narrower than the 8-cent estimate, and revenue of about $0.57M versus a $0.50M estimate. Revenue grew for a sixth straight quarter. POET ended with $796.3M cash after a $400M financing and a registered direct offering at $21 per unit.
4 min readPOET Technologies appointed Bardia Pezeshki and Jean F. Rankin to its board of directors and accepted Jean-Louis Malinge’s resignation for personal reasons. Pezeshki has optical communications and micro-LED interconnect experience. Rankin brings public-company governance and IP expertise. CEO Suresh Venkatesan said the changes support POET’s technology commercialization and AI/data center expansion.
2 min readSimply Wall St reports POET Technologies (Nasdaq: POET) drew attention after Alphabet said it plans about $200b in AI infrastructure using advanced optical networking, an area where POET supplies photonic components. POET also refreshed its board, appointing Dr. Bardia Pezeshki and Jean F. Rankin effective 1 Aug 2026. The article cites POET’s P/B of 3.3x vs ~5x peers and recent share moves.
6 min readInvesting.com reports that Poet Technologies Inc. (POET) shares could swing about 11% around its Aug. 14 earnings release, based on Bloomberg options data. The article says actual post-earnings moves exceeded implied options in 6 of the past 8 reports, with several examples cited.
2 min readPOET Technologies shares rose 5.7% pre-open after Reuters reported the FCC is drafting a ban on imports of new Chinese-made optical transceivers, citing cybersecurity risks. JPMorgan said a strong NFP could trigger selloffs, but the sector rallied. POET is seen as a beneficiary of supply-chain shifts, supported by its Optical Interposer platform and recent board appointments. Stock moved from $8.53 to $9.02.
3 min readShares of COHR, LITE, POET, AAOI, and MRVL rose after a report said Trump is considering a ban on certain China-made data center import parts. The proposal aims to address cybersecurity concerns and is not finalized, with possible changes before publication. Restrictions would likely target Zhongji Innolight, added to a Pentagon list in June.
2 min readPoet Technologies (NASDAQ:POET) shares trade at $8.33 after Q1 2026 revenue rose 201.86% year over year, but sentiment was pressured by late-June class action allegations, CEO Thomas Mika’s July 8 retirement, and a $400M direct offering. A model targets $22.23 by 2027 versus $17.50 Street consensus, with a $25 bull case.
5 min readThe article highlights AI data-center optical demand across five public companies. POET (POET) expects to ship 30,000+ optical engines in 2026, funded by about $430M cash. Coherent (COHR) reports Datacenter & Communications revenue of $1.362B (+40.6% YoY). Fabrinet (FN) Q3 FY26 revenue $1.214B (+39.3%) and capex $63.8M (+121%). IPG Photonics (IPGP) Q1 FY26 revenue $265.5M (+16.6%) and authorizes a $100M buyback. nLIGHT (LASR) Q1 FY26 revenue $80.18M (+55.2%) and EPS beat.
7 min readPOET Technologies (NASDAQ:POET) shares rose 3.06% to $8.76 on Thursday, supported by a broader Nasdaq-100 gain of 1.4% and risk-on rotation into high-beta tech. The stock is 13.2% above its 200-day SMA ($7.85) but 16.1% below its 20-day ($10.58) and 23.8% below its 50-day ($11.66), with MACD still negative.
3 min read
